ANNUAL MEETING DEADLINES

Abstract Submission
June 6, 2016
Early (Reduced) Registration
September 9, 2016
Advance Registration
October 20, 2016
Hotel Reservations
Exhibitors: October 1, 2016
Attendees: October 10, 2016

EXHIBITOR DEADLINES

Reduced Exhibit Rates
April 25, 2016
Regular Exhibit Rates
June 30, 2016 (based on availability)
Sponsorship Opportunities
Deadlines Vary
Advertising Opportunities
Deadlines Vary
Corporate Workshop App
July 15, 2016

AWARD APPLICATION DEADLINES

Technologist
May 31, 2016
Young Investigator
May 31, 2016
Technologist Travel
July 25, 2016
International Trainee Travel
July 25, 2016
ICPI Trainee Travel
TBD

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP

Volunteer

Corporate Partners
Diamond Partners
Abbott Molecular
Hologic
Nanostring
Roche
Platinum Partners
BD
Luminex
Gold Partners
Asuragen
Silver Partners

AgenaBD

Illumina

Novartis

Qiagen

Thermo Fisher Scientific

AMP 2016 Annual meeting - Big World. Molecular Medicine. One Community.

Scientific Program

Thank you for your interest in the AMP 2016 Annual Meeting! The program is being developed by the AMP 2016 Annual Meeting Program Committee and should be final by June. Check back often for updates.

Quick Links:

Thursday

Friday

Saturday

PDF of Program Mobile App

 

Tuesday, November 8, 2016

 

8:30am - 5:15pm AMP References Material Forum (Separate Registration)
10:30am- 11:15am
Executive Committee Meeting (Invitation Only)
11:30am- 6:00 pm

Board of Directors Meeting (Invitation Only)

1:00pm- 6:00pm Attendee, Speaker and Exhibitor Registration and Check-In
6:30pm

Board of Directors Dinner (Invitation Only)

   

 

Wednesday, November 9, 2016

 

7:00am - 5:00pm Attendee, Speaker and Exhibitor Registration and Check-In
7:30am - 5:00pm AMP Committee Meetings (Invitation Only)
7:30am- 8:30am Registration, Continental Breakfast for Outreach Course
8:00am - 5:00pm Corporate Workshop Day (No registration required!)
8:30am - 3:45pm Molecular Pathology Outreach Course (MPOC) (Separate Registration)
8:30am - 3:45pm Science Educator Workshop (Separate Registration)
5:00pm- 6:00pm Volunteer Appreciation Reception (Invitation Only)
6:00pm- 7:00pm MGP Program Directors Meeting (Invitation Only)
6:15pm- 8:30pm International Showcase (Separate Registration)

 

Thursday, November 10, 2016

 
GENERAL INFORMATION
6:30am - 8:00am Poster Set-Up
7:00am - 5:00pm Attendee, Speaker, and Exhibitor Registration and Check-In
7:00am - 8:00am Continental Breakfast
11:30am - 4:30pm Exhibit Hall Open
   
SCIENTIFIC PROGRAM
7:00am - 8:00am EARLY BIRD SESSIONS
   
 

Design, Validation, and Implementation of Effective Quality Control Materials for NGS/NIPS in a Clinical Laboratory

   
    Development of Reference Materials for Proficiency Testing and Quality Assurance
Lisa V. Kalman, PhD, Centers for Disease Control and Prevention, Atlanta, GA, USA
   
    External Proficiency Assessment of Prenatal Cell Free (cf)DNA Testing for Aneuploidy
Glenn E. Palomaki, PhD, Women & Infants Hospital,
Providence, RI, USA

   
  Data Security, Privacy, and Working in the Cloud: What Every Lab Director Should Know
   
    The Promise and Perils of Using Cloud-Based Informatics Solutions for Human Genomic Data Analysis and Sharing
Alexis B. Carter, MD, Children's Healthcare of Atlanta, Atlanta, GA, USA
   
 

Case Studies in Solid Tumors

   
    ALK Expression in a Non-small Cell Lung Cancer Not Associated with ALK Rearrangement by FISH or by Targeted NGS-based Fusion Assay
Patrick Mann, MD, University of Colorado Hospital,
Aurora, CO, USA
     
    ALK-rearranged Adenocarcinoma with Transformation to High Grade Neuroendocrine Carcinoma at a Metastatic Site Showing Retained ALK Rearrangement
Jill Miller, MD, University of Vermont Medical Center,
Burlington, VT, USA
     
    Next-Generation Sequencing Panels Aid in the Diagnosis of Rare Collision Tumors
Jonas J. Heymann, MD, New York-Presbyterian
Hospital-Columbia University Medical Center,
New York, NY, USA

     
    Identification of a Silent EGFR Mutation Leading to Allele Dropout in EGFR p.L858R Genotyping
Helio A. Costa, PhD, Stanford University, Stanford,CA, USA
     
 

Case Studies in Hemepath

   
    5q Microdeletion Identified via Microarray Analysis Allows for Targeted Therapy in B-Lymphoblastic Leukemia
Kendall Brewer, MD, Medical University of South
Carolina, Charleston, SC, USA
     
    The Use of Next-Generation Sequencing (NGS) to Identify a Case of Clonal Cytopenias of Undetermined Significance (CCUS)
Meghan Riley, MD, Washington University, St. Louis,
MO, USA
     
    Donor-derived Clonal Hematopoiesis in an Acute Myeloid Leukemia (AML) Patient with History of Sex-mismatched Peripheral Blood Stem Cell Transplantation
Alissa Minkovsky, MD, PhD, Brigham and Women’s
Hospital, Boston, MA, USA
     
    A Case of Undiagnosed Diamond Blackfan Anemia
Tripti Kumar, DO, Beaumont Health System, Royal
Oak, MI, USA

     
 

Case Studies in Infectious Diseases

     
    Culture Negative Endocarditis Due to Tropheryma whipplei
Catherine Stefaniuk, DO, Case Western Reserve University, University Hospitals - Cleveland Medical
Center
     
    Histopathologic Findings and the Diagnosis of CNS Tropheryma whipplei on Paraffinembedded Tissue
Andrew Bryan, MD, PhD, University of Washington,
Seattle, WA, USA
     
8:00am - 8:15am Break
   
8:15am - 8:30am

Opening Remarks

Victoria M. Pratt, PhD, Indiana University Medical Center, Indianapolis, IN, USA and 2016 Program Chair

   
8:30am - 9:45am

AMP Award for Excellence in Molecular Diagnostics: Presentation and Lecture

   
  Secrets of the Human Genome: The 35-year Journey of Genomic Medicine
  Eric S. Lander, PhD, Broad Institute of Harvard and MIT, Cambridge, MA, USA
   
9:45am -10:15am Coffee Break
   
10:15am - 11:45am INFORMATICS PLENARY SESSION
  Its a Big Data World. Leveraging Available Genomic and Clinical Data to Advance Diagnostics
   
    Translating a Trillion Points of Data into Therapies, Diagnostics, and New Insights into Disease
Atul Butte, MD, PhD, University of California, San Francisco, San Francisco, CA, USA
   
    Clinical Informatics
Christopher G. Chute, MD, DrPH, Johns Hopkins University, Baltimore, MD, USA
   
11:45am - 1:00pm General Lunch - Visit Exhibit Hall and View Posters
  Networking Lunches (schedule)
   
1:00pm - 2:30pm CONCURRENT WORKSHOPS
   
 

Molecular Basis of Immune Diversity and Emerging Clinical Applications

   
    Analysis of Immunoglobulin Genetics
Scott D. Boyd, MD, PhD, Stanford University, Stanford, CA, USA
   
    Learning to Read the Adaptive Immune Repertoire
Harlan Robins, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
   
 

Laboratory Test Utilization: It’s Never Too Late to Start

   
    Genetic Testing Utilization Management: The DHMC Experience
Mary Beth P. Dinulos, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
   
    Development of a Multifaceted Laboratory Utilization Program
Jeffrey S. Warren, MD, University of Michigan, Ann Arbor, MI, USA
   
 

Liquid Biopsies and Analysis of Cell Free DNA in Cancer Patients

   
    Liquid Biopsy
Michael R. Speicher, MD Medical University of Graz, Graz, Austria
   
    ctDNA Analysis
Maximillian Diehn,MD, PhD, Stanford University, Stanford, CA, USA
   
 

Assay Validation and the FDA Process

   
    Principles of Molecular Assay Validation
Margaret L. Gulley, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
   
    Regulation of Laboratory Developed Tests
Speaker TBD
 
  From Guidelines to Clinic: Incorporating Pharmacogenetics into Clinical Practice
   
    HLA and Pharmacogenetics
Maria P. Bettinotti, PhD, Johns Hopkins University, Baltimore, MD, USA
   
    The Clinical Pharmacogenetics Implementation Consortium: Incorporating Pharmacogenetics into Clinical Practice
Kelly E. Caudle, PharmD, PhD, St. Jude Children's Research Hospital, Memphis, TN, USA
   
2:30pm - 4:15pm

Coffee Break - Visit Exhibit Hall and Attend Poster Walks

(Award Applicant Posters Attended. Poster Walks start & end at AMP Central)

   
4:15pm - 5:45pm CONCURRENT SYMPOSIA
   

CHIPping Away at the Mysteries of Hematopoiesis: The Science and Clinical Implications of Clonal Hematopoiesis of Indeterminate Potential

    Clonal Hematopoiesis of Indeterminate Potential
Benjamin Ebert, MD, PhD Brigham and Women's Hospital, Boston, MA, USA
   
    CHIP, ICUS, MDS: A Clinical Perspective
David P. Steensma, MD, Dana-Farber Cancer Institute, Boston, MA, USA
   
  A View from Across the Pond: European Models for Molecular Infectious Disease Testing

 

    Testing Models for Clostridium difficile Infection Used in the UK
Mark Wilcox, MD, FRCPath, Leads Teaching Hospital & University of Leeds, Leeds, West Yorkshire, UK
   
    HPV Primary Screening: Challenges of Application and Implementation - and Priorities for Research
Kate Cuschieri, BSc, PhD, NHS Lothian, Edinburgh, United Kingdom
   
5:45pm - 7:00pm Welcome Reception (Supported by Roche)
   
7:30pm - 9:00pm JMD Editorial Board Dinner (Invitation Only)
   
7:30pm - 9:00pm Canadian Member Dinner
   
7:30pm - 9:00pm Indian Member Dinner
 

 

Friday, November 11, 2016

 
GENERAL INFORMATION
7:00am - 5:00pm Attendee, Speaker, and Exhibitor Registration and Check-In
7:00am - 8:00am Continental Breakfast
9:00am - 4:30pm Exhibit Hall Open
     
SCIENTIFIC PROGRAM
7:00am - 8:00am EARLY BIRD SESSIONS
   
 

Variant Calling Workflow Processes

   
    Streamlining Big Data Analysis for Personalized Genomics: A Genomics Laboratory Approach
Lora J. H. Bean, PhD, Emory University, Atlanta, GA, USA
   
    Rare Variants and Alternate Splice Prediction: Tools from GT to AG
Brian H. Shirts, MD, PhD, University of Washington, Seattle, WA, USA
   
 

Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine, An IOM report

   
    Biomarker Tests for Molecularly Targeted Therapies: Am Institute of Medicine Report
Debra G.B. Leonard, MD, PhD, University of Vermont Medical Center, Burlington, VT, USA
   
    IOM Report on Biomarkers
Robert L. Nussbaum, MD, Invitae, Inc., San Francisco, CA, USA
 
 

PAMA is Here: What Your Lab Should be Doing Today!
(Sponsored by the Economic Affairs Committee)

   
    Overview of PAMA: What Is It and Why Is It Important for You?
Samuel K. Caughron, MD, MAWD Pathology Group, North Kansas City, MO, and EAC Chair
   
    PAMA Data Collection and Reporting Requirements
Federico A. Monzon, MD, Castle Biosciences, Friendswood, TX, and President-Elect
   
    Operationalizing PAMA Data Collection and Reporting at Your Institution
Roger D. Klein, MD, JD, The Cleveland Clinic Foundation, Cleveland, OH, USA and PRC Chair
 
  VITAL (Variant Interpretation Test Across Labs) Information for Genetic Variant Interpretation
(Sponsored by the Clinical Practice Committee)
   
    Elaine Lyon, PhD, ARUP Laboratories, Salt Lake City, UT, USA and Past AMP President
   
 

Challenging Case Studies in Informatics

 
    Acute Myeloid Leukemia with Exon 12 NPM1 Mutation and a Somatic Mutation in the Poly-T Sequences – A Possible Pitfall
Pawel Mroz, MD, PhD, University of Michigan, Ann Arbor, MI, USA
     
    GLIOSEQ Targeted Next-Generation Sequencing Panel Provides Clinically Relevant Profiling of a Challenging Brain Tumor: A Proof-of-Concept Case
Soufiane El Hallani, MD, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
     
    Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Gland: A Primary Thyroid Adenocarcinoma Harboring ETV6–NTRK3 Fusion
Deepu Alex, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
     
    Re-classification of a Salivary Gland Neoplasm by a Next Generation Sequencing Gene Fusion Assay
Daniel Xia, MD, Massachusetts General Hospital,Boston, MA, USA
     
   
8:00am - 8:15am Break
     
8:15am - 9:45am INFECTIOUS DISEASES PLENARY SESSION
  The Human Microbiome in Health and Disease
   
    Placental Microbiome and Human Pregnancy
Indira U. Mysorekar, PhD, Washington University in St. Louis, St. Louis, MO, USA
   
    The Microbiome of Cystic Fibrosis
John J. LiPuma, MD, University of Michigan Medical School, Ann Arbor, MI, USA
   
9:45am - 10:45am

Coffee Break - Visit Exhibit Hall and Attend Poster Walks

Even-Numbered Posters Attended. Poster Walks start & end at AMP Central (Schedule)

     
10:45am - 11:45am

CONCURRENT WORKSHOPS:

Platform Presentations of Selected Abstracts

  Abstracts are selected by the Program Committee
   
  Genetics Platform Presentations
     
    G30 - ROH-Associated UPD In Mosaic Trisomy Cases Occurs Infrequently and Detection Is Likely Influenced By Positive Selection Against the Trisomic Cell Line
Peter R. Papenhausen, PhD, Laboratory Corporation of America, Center for Molecular and Biological Pathology, Research Triangle Park, NC, USA
     
    G40 - Adapting the ACMG/AMP Variant Classification Guidelines for Inherited Cardiomyopathy: A Pilot Study of Clingen’s International Expert Working Group
Jillian Buchan, PhD, Stanford University School of Medicine, Palo Alto, CA, USA
     
    G48 - Carrier Screening Using a Genomic Approach: Future Directions for Clinical Laboratory Testing?
Sumit Punj, PhD, Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR, USA
     
    G52 - What Have Public Databases Taught Us About Variant Classification? The Example of BRCA1 And BRCA2
Stephen E. Lincoln, Invitae, San Francisco, CA, USA
     
  Hemepath Platform Presentations
     
    H06 - The Utility of Next-Generation Sequencing in the Diagnosis of Myelodysplastic Syndrome
Adrian H. Box, MD, PhD, Emory University School of Medicine, Atlanta, Georgia, USA
     
    H26 - Mutational Shift in Acute Myeloid Leukemia (AML) Relative to Therapy and Disease Progression
Priya D. Velu, MD, PhD, University of Pennsylvania, Philadelphia, PA, USA
     
    H28 - Comprehensive Detection of Balanced Translocations in B-Cell Lymphoproliferative Disorders by Massively Parallel Sequencing
Philippe Szankasi, PhD, ARUP Laboratories, Salt Lake City, UT, USA
     
    H52 - A Targeted Next-generation DNA Sequencing Panel Detects Novel Rearrangements in Hematopoietic Malignancies
Daimon P. Simmons, MD, PhD, Brigham and Women’s Hospital, Boston, MA, USA
     
  Infectious Diseases Platform Presentations
     
    ID04 - Hepatitis C Virus Genotyping of Organ Donor Samples to Aid in Transplantation of HCV-positive Organs
Caren Gentile, MS, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
     
    ID10 - A Metagenomic Investigation of Microbiota of Healthy Trachea
Young Jin Kim, MD, PhD, Kyung Hee University Hospital, Seoul, Korea
     
    ID42 - Genomics for Herpes Simplex Virus 2: Transmission, Recombination, and Antiviral Resistance
Alex Greninger, MD, PhD, University of Washington, Seattle, WA, USA
     
    ID44 - A Laboratory-Developed Metagenomic NGS Assay for Pathogen Detection in CSF Specimens
Samia Naccache, PhD, University of California San Francisco, San Francisco, CA, USA
     
  Informatics Platform Presentations
     
    I14 - Analysis of Publicly Available Chronic Lymphocytic Leukemia Karyotype Data Using a Karyotype Parsing and Mapping Informatics
Approach

Zachary Abrams, PhD, The Ohio State University, Columbus, OH, USA
     
    I29 - Evolution of a Clinical Exome Sequencing Bioinformatics Pipeline in Pediatrics: Improvements, Validation, Challenges
Chao Wu, PhD, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
     
    I24 - An Integrative Multi-software Approach for FLT3 Internal Tandem Duplication Detection in Hybrid Capture next Generation Sequencing Data
Sabah Kadri, PhD, University of Chicago, Chicago, IL, USA
     
    I36 - Computational Methods for Detection of Somatic Mutations at .05% Frequency From cfDNA Using Molecular Tagging and High Throughput Multiplex Next-generation Sequencing
Dumitru Brinza, PhD, Thermo Fisher Scientific, South San Francisco, CA, USA
     
  Solid Tumors Platform Presentation
     
    S42 - Evaluation of a Panel of 7 DNA Methylation Biomarkers to Distinguish between Histological Subtypes of Ovarian and Endometrial Carcinomas
Michaela Campan, PhD, University of Southern California, Los Angeles, CA, USA
     
    S50 - Clinical Utility of Whole Transcriptome (RNA-seq) Analysis for Detection of Fusions and Gene Expression in Thyroid FNA and Fixed Tissue Samples
Marina N. Nikiforova, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
     
    S90 - Study of Pre-analytic Parameters for Standardization of Cell-Free DNA Isolation from Plasma in a CLIA-approved Molecular Diagnostics Laboratory
Meenakshi Mehrotra, PhD, The University of Texas MD Anderson Cancer Center, Houston , TX, USA
     
    S118 - Clinical Validation of Plasma Cell Free DNA Mutation Detection in Patients with EGFR-Mutated Lung Cancer
Lynette M. Sholl, MD, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
     
11:45am - 1:00pm General Lunch - Visit Exhibit Hall and View Posters
  Networking Lunches (schedule)
   
1:00pm - 2:30pm CONCURRENT SYMPOSIA
   

Clinical Laboratory Data Analysis: How Advances in Informatics Systems Will Power the Future of Laboratory Testing

    Precision Diagnosis for Precision Medicine: Case Studies in Knowledge Visualization and Decision Support
Mark S. Boguski, MD, PhD, Precision Medicine Network, Boston, MA, USA
   
    Watson Genomics: Moving Forward on Personalized Medicine
Filippo Utro, PhD, IBM T.J. Watson Research Center, Yorktown Heights, NY, USA
   

Genomics and Immunologics for Managing Cancer

   
    Molecular Classification of Glioblastoma and the Implication for Therapy
Kenneth Aldape, MD, University Health Network, Toronto, Ontario, Canada
   
    Emerging Immunologic Biomarkers: PD-L1 and Beyond
Janis M. Taube, MD, MSc, Johns Hopkins University School of Medicine, Baltimore, MD, USA
 

 

2:30pm - 3:30pm

Coffee Break - Visit Exhibit Hall and Posters

(Even-Numbered Posters Attended)

   
3:30pm - 5:00pm

HEMATOPATHOLOGY PLENARY SESSION

   
  Check It Out! The Scientific Basis and Clinical Application of Check-Point Inhibitor Therapy for a Broad Range of Cancer Types
   
    Immune Checkpoint Blockade in Lymphoma
Stephen M. Ansell, MD, PhD, Mayo Clinic, Rochester, MN, USA
   
    Personal Tumor Neoantigens: Discovery and Immunotherapeutic Targeting
Catherine J. Wu, MD, Dana-Farber Cancer Institute, Boston, MA, USA
   
3:30pm- 5:00pm

Infectious Diseases Subdivision Town Hall

   
5:00pm - 5:15pm Break
   
5:15pm - 6:30pm

Business Meeting and Awards Session

(Open to All Registered Attendees)

   
7:00pm - 10:30pm

AMP 2016 Social Event

 

 

 

Saturday, November 12, 2016

 
GENERAL INFORMATION
7:00am - 2:00pm Attendee, Speaker, and Exhibitor Registration and Check-In
7:00am - 8:00am Continental Breakfast
9:00am - 1:30pm Exhibit Hall Open
1:00pm - 1:30pm Poster Removal
   
SCIENTIFIC PROGRAM
7:00am - 8:00am EARLY BIRD SESSIONS

More Toy Stories - Up and Coming Cool Platforms for Molecular Infectious Diseases Testing

   
    Idylla™, A New "clinical sample" in - "qPCR-based" Out Molecular Diagnostic Platform
Rudi Pauwels, Biocartis, Mechelen, Belgium
   
    Next Generation POC Molecular Dx
Kyle Armantrout, Tetracore, Inc., Rockville, MD, USA
   
    Using Long Read Sequencing as a Tool to Examine Host-Pathogen Relationships
Melissa Laird Smith, PhD, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Making Sense of Genomic Variation in Chronic Myeloid Neoplasms (CMNs): Findings from a Recent Review of the Literature by the AMP CMN Working Group

   
   

Presented by Members of the AMP CMN Working Group:
Annette S. Kim, MD, PhD, Brigham and Women’s Hospital (Harvard Medical School), Boston, MA, USA


Mark D. Ewalt, MD, Cedars Sinai Medical Center, Los Angeles, CA, USA

 

New Standards and Guidelines for Validation, Interpretation and Reporting of NGS-based Oncology Tests
(Sponsored by the Clinical Practice Committee)

     
    Introduction
Marina N. Nikiforova, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
     
    Standards and Guidelines for Development, Optimization and Validation of NGS-based Oncology Panels
Lawrence J. Jennings, MD, PhD, Lurie Children’s Hospital of Chicago, Chicago, IL, USA
     
    Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Marilyn M Li, MD, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
 
  Platform Presentations of Selected Techincal Topics Abstracts
     
    TT06 - The Use of Biosynthetic Controls as Performance Standards for NGS Assays of Somatic Tumors: A Multi-laboratory Study
Sophie J. Deharvengt, PhD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
     
    TT28 - Microfluidic Seperation and Detection of Circulating Tumor Cells from Blood Samples
Jin-Yeong Han, MD, PhD, Dong-A University College of Medicine, Busan, South Korea
     
    TT30 - Detection of EGFR Mutations in ctDNA by PNA Clamping-assisted Fluorescence Melting Curve Analysis
Hyunsun Kim, PANAGENE Inc., Seoul, South Korea
     
    TT48 - Automation of NGS Workflow for Processing of High Sample Volume in a Clinical Laboratory
Abigail Wald, PhD, University of Pittsburgh Medical
Center, Pittsburgh, PA, USA
   
  Case Studies in Genetics
    Compound Melanocytic Nevus and Rhadomyosarcoma in Setting of HRAS Mutation.
Paul Lee, MD, PhD, Washington University, St. Louis, MO, USA
     
    Research Whole Exome Sequencing Identifies a Genetic Diagnosis of Neuronal Ceroid Lipofuscinosis Type 6 after a Panel Test Miss
Nicole J. Boczek, PhD, Mayo Clinic, Rochester, MN, USA
     
    A Hematopoietic Chimera Case Identified by Chromosomal Microarray
Yang Cao, PhD, Mayo Clinic, Rochester, MN, USA
     
    Maternally Inherited 133 kb Deletion of 14q32 Causing a Paternal UPD14 Phenotype (Kagami- Ogata Syndrome)
Hou-Sung Jung, PhD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
     
8:00am - 8:15am Break
   
8:15am - 9:45am SOLID TUMORS PLENARY SESSION
   
  From Actionable Targets to Emerging Resistance
   
    Matching Drugs to Actionable Targets
Lillian L. Siu, MD, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
   
    Molecular Harbingers of Prostate Cancer Drug Resistance
Mark A. Rubin, MD, Weill Cornell Medicine, New York, NY, USA
   
9:45am - 10:45am

Coffee Break - Visit Exhibit Hall and Attend Poster Walks

Odd-Numbered Posters Attended. Poster Walks start & end at AMP Central (Schedule)

   
10:45am - 12:15pm CONCURRENT WORKSHOPS
   
  A Tale of Two Approaches: Tumor vs Tumor-Normal samples for Clinical Somatic Variant Detection
     
    Comprehensive Cancer Genomic Profiling by Tumor-Only Testing
Garrett Michael Frampton, PhD, Foundation Medicine, Cambridge, MA, USA
   
    Tumor-Normal Somatic Sequencing
Victoria M. Raymond, MS, Trovagene, Inc., San Diego, CA, USA
     
    Benefits of Returning Germline Cancer Susceptibility Results
Sharon E. Plon, MD, PhD, Baylor College of Medicine,
Houston, TX, USA

   

Process Improvement to Reduce Errors in Diagnostics

   
    Precision Diagnosis Is a Team Sport
Barbara A. Zehnbauer, PhD, Emory University, Atlanta, GA, USA
   
    QMS (Combining Lean and Six Sigma)
John Q. Miller, Quest Diagnostics, Dallas, TX, USA
Practical Aspects in Implementing Clinical NGS Tests in Microbiology
   
    Overview of NGS Technology
Benjamin A. Pinsky, MD, PhD, Stanford University School of Medicine, Stanford, CA, USA
   
    Unbiased Detection of Bacterial Pathogens Directly From Specimens by Next-Generation Sequencing in the Diagnostic Laboratory
Robert Schlaberg, MD, Dr. med., MPH, University of Utah, Salt Lake City, UT, USA
   
 

Cystic Fibrosis Carrier Screening in a Post-CFTR2 World

   
    History of the First Universal Molecular Carrier Screen: Lessons for Genomic Medicine
Wayne W. Grody, MD, PhD, UCLA School of Medicine, Los Angeles, CA, USA
   
    CF Carrier Screening
Garry Cutting, MD, Johns Hopkins School of Medicine, Baltimore, MD, USA
   
 

CAP-IASLC-AMP Molecular Testing Guideline for Selection of Lung Cancer Patients: Application of the Updated Draft Recommendations in Clinical Practice

(Sponsored by the Clinical Practice Committee)

   
    Revised Guidelines for Clinical Molecular Diagnostics in Lung Cancer
Neal I. Lindeman, MD, Brigham & Women’s Hospital, Boston, MA, USA
     
    Panel Discussion
Neal I. Lindeman, MD, Brigham & Women’s Hospital, Boston, MA, USA
Eric Bernicker, MD, Houston Methodist Hospital, Houston, TX, USA
Ming S. Tsao, MD, University Health Network and Princess Margaret Cancer Centre, Toronto, Canada
   
12:15pm - 1:30pm General Lunch - Visit Exhibit Hall and View Posters
  Networking Lunches (schedule)
   
1:30pm - 3:00pm CONCURRENT SYMPOSIA
   

AMP v. Myriad:  What Have We Learned Since Then

    AMP vs. Myriad: 3 Years Later
Roger D. Klein, MD, JD, Cleveland Clinic, Cleveland, OH, USA
Timothy Stenzel, MD, PhD, Invivoscribe, San Diego, CA, USA
   
Zika Virus: Beyond Fear to Understanding and Addressing the Current Challenges
     
    Epidemiology and Preparations for the Emergence of Zika Virus
Anna Likos MD, MPH, Florida Department of Health, Division of Disease Control, Tallahassee, Florida, USA
     
    Laboratory Testing for the Zika Virus
Benjamin Pinsky, MD, PhD, Stanford University, Stanford, CA, USA
     
3:00pm - 3:15pm Break
   
3:15pm - 4:45pm PLENARY SESSION
   
 

Patient Access to Clinical Laboratory Testing Information
(Sponsored by the Professional Relations Committee)

     
    Patient Access to Genetic Data
Sandra Park, JD, American Civil Liberties Union, New York, NY, USA
     
    Patient Perspective on Access to Genetic Data
Ken Deutsch, Patient Complainant in Myraid Filing, Cambridge, MA, USA
     
    VITAL Information for Genetic Variant Interpretation
Elaine Lyon, PhD, ARUP Laboratories, Salt Lake City, UT, USA and Past AMP President
     
    The Legal Environment for the Return of Genomic Screening Data
John M. Conley, JD, PhD, University of North Carolina School of Law, Chapel Hill, NC, USA
     
    Panel Discussion
   
4:45pm - 5:00pm

Closing Remarks

Victoria M. Pratt, PhD, indiana University Medical Center, Indianapolis, IN, USA and AMP Program Committee Chair